Lv3
250 积分 2022-04-13 加入
How I prevent GVHD in high-risk patients: posttransplant cyclophosphamide and beyond
6天前
已关闭
Post-transplantation cyclophosphamide as GVHD prophylaxis in allogenic hematopoietic stem cell transplantation: Recent advances and modification
6天前
已完结
Opportunistic Infections in Patients Receiving Post-Transplantation Cyclophosphamide: Impact of Haploidentical versus Unrelated Donor Allograft
6天前
已完结
Believe in haploidentical HSCT: less is better
8天前
已关闭
Believe in haploidentical HSCT: less is better
8天前
已关闭
Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation
8天前
已完结
Late‐onset Pneumocystis jirovecii pneumonia post‐allogeneic stem cell transplantation after time‐dependent discontinuation of prophylaxis
10天前
已完结
The dynamics of B‐cell reconstitution post allogeneic hematopoietic stem cell transplantation: A real‐world study
11天前
已完结
Classification of treatment-related mortality in children with cancer: a systematic assessment
12天前
已完结
Incidence of breakthrough fungal infections on isavuconazole prophylaxis compared to posaconazole and voriconazole
17天前
已完结
皖公网安备34019202002308
